Metabolism of formycin B by Leishmania amastigotes in vitro. Comparative metabolism in infected and uninfected human macrophages.
Authors:
- J D BermanJBJ D Berman
- P RaineyPRP Rainey
- D V SantiDSD V Santi
Open Access
- 1 July 1983
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 158 (1) , 252-257
Abstract
Formycin B is metabolized by cutaneous Leishmania amastigotes within cultured human macrophages to give formycin B 5'-monophosphate and formycin A 5'-mono-, di-, and triphosphates. Formycin A is also incorporated into RNA. The activity of formycin B against amastigotes was correlated with the levels of formycin A metabolites formed in the parasites. Uninfected macrophages also convert formycin B into the same products, but the levels are markedly lower than those seen in infected macrophages. The results suggest that a sufficient therapeutic index exists to warrant consideration of formycin B as an anti-leishmanial drug in humans.Keywords
This publication has 6 references indexed in Scilit:
- Metabolism and mechanism of action of formycin B in Leishmania.Proceedings of the National Academy of Sciences, 1983
- The metabolism of formycin B in LeishmaniadonovaniBiochemical and Biophysical Research Communications, 1982
- In Vitro Susceptibility of Antimony-Resistant Leishmania to Alternative DrugsThe Journal of Infectious Diseases, 1982
- Phosphorylation and anti-leishmanial activity of formycin BBiochemical and Biophysical Research Communications, 1981
- An Analytical System for Rapid Separation of Tissue Nucleotides at Low Pressures on Conventional Anion ExchangersClinical Chemistry, 1975
- Studies on formycin and formycin B in cells of Ehrlich carcinoma and E. coli.1967